Scholarlink

Introduction <p>Vein of Galen malformation (VOGM) is a rare and severe congenital arteriovenous malformation. Its therapeutic results are complex and often catastrophic, making its treatment a true challenge.</p> Historical background <p>VOGM is characterized by the persistence of direct arteriovenous communications between the choroidal feeding arteries and the embryonic vein, known as the median prosencephalic vein of Markowski.</p> Clinical presentation, diagnosis, and pathophysiology <p>The malformation develops between the 8th and 11th weeks of gestation. Diagnostic suspicion is usually made through fetal ultrasound after the 18th week of gestation or later. Fetal MRI complements the diagnosis.</p> Management, prognosis, and outcomes <p>There are two groups of patients with VOGM: severe cases, with persistent high-flow arteriovenous shunts leading to multiorgan failure, and mild cases with a lower mortality rate and a more favorable outcome. The use of vascular parameters, based on the diameter of the falcine sinus measured by fetal MRI, can serve as a predictor of neonatal outcome and therapeutic choice.</p> Case report <p>A 33-year-old primigravida presented with a fetus diagnosed with VOGM by fetal ultrasound at 32&#xa0;weeks of gestation. An aneurysmal dilation of the Galen vein was observed, with a transverse falcine sinus measuring 10.5&#xa0;mm. Aneurysm dilatation dimensions: 25 × 21 × 20&#xa0;mm. Fetal MRI confirmed a falcine sinus width of 10.5&#xa0;mm, indicating a 96% chance of poor outcome. Fetal embolization of the VOGM was performed, followed by postnatal treatment.</p> Conclusions <p>In this article, we review the main principles of VOGM management and present a case treated during pregnancy, illustrating a potential therapeutic strategy. We suggest that fetal embolization of VOGM, when appropriately indicated, may represent an emerging approach in the management of this severe condition.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Galen vein malformation—intrauterine treatment

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月25日

查看全文
  • Sergio Cavalheiro,
  • Marcos Devanir Silva da Costa,
  • Paloam Cardoso Nôvo,
  • Michel Eli Frudit,
  • Fernando Seiji Suzuki,
  • Maurício Mendes Barbosa,
  • Patrícia Alessandra Dastoli,
  • Stéphanno Gomes Pereira Sarmento,
  • Ítalo Capraro Suriano,
  • Antônio Fernandes Moron

摘要

Introduction

Vein of Galen malformation (VOGM) is a rare and severe congenital arteriovenous malformation. Its therapeutic results are complex and often catastrophic, making its treatment a true challenge.

Historical background

VOGM is characterized by the persistence of direct arteriovenous communications between the choroidal feeding arteries and the embryonic vein, known as the median prosencephalic vein of Markowski.

Clinical presentation, diagnosis, and pathophysiology

The malformation develops between the 8th and 11th weeks of gestation. Diagnostic suspicion is usually made through fetal ultrasound after the 18th week of gestation or later. Fetal MRI complements the diagnosis.

Management, prognosis, and outcomes

There are two groups of patients with VOGM: severe cases, with persistent high-flow arteriovenous shunts leading to multiorgan failure, and mild cases with a lower mortality rate and a more favorable outcome. The use of vascular parameters, based on the diameter of the falcine sinus measured by fetal MRI, can serve as a predictor of neonatal outcome and therapeutic choice.

Case report

A 33-year-old primigravida presented with a fetus diagnosed with VOGM by fetal ultrasound at 32 weeks of gestation. An aneurysmal dilation of the Galen vein was observed, with a transverse falcine sinus measuring 10.5 mm. Aneurysm dilatation dimensions: 25 × 21 × 20 mm. Fetal MRI confirmed a falcine sinus width of 10.5 mm, indicating a 96% chance of poor outcome. Fetal embolization of the VOGM was performed, followed by postnatal treatment.

Conclusions

In this article, we review the main principles of VOGM management and present a case treated during pregnancy, illustrating a potential therapeutic strategy. We suggest that fetal embolization of VOGM, when appropriately indicated, may represent an emerging approach in the management of this severe condition.